Eating behavior in patients with metabolically associated fatty liver disease
https://doi.org/10.31146/1682-8658-ecg-225-5-90-99
Abstract
The purpose of this study was to study the phenotypes of eating behavior in patients with NAFLD and their determining factors. Discussion: fatty liver disease has a high prevalence (24-26%) with an upward trend in both developed and developing countries, and in the coming years may become one of the main causes of liver transplantation. The clinical features of the disease are in most cases its asymptomatic course, which can progress to fibrosis/cirrhosis and is associated with the risk of a number of serious extrahepatic diseases (cardiovascular, oncological and others). The mechanisms underlying the formation of increased health risks and disease prognosis are multifactorial. Metabolic disorders, orthorexia nervosa, eating disorders and vegetative effects are considered as possible pathogenetic mechanisms for increasing the risk of NAFLD incidence. Conclusion: the study showed that complex behavioral psycho-social factors are involved in the pathogenesis of NAFLD, and changing eating behavior is an important component of therapy. Dysfunctional eating behavior can be a barrier to long-term success from therapy.
About the Authors
A. A. Khalashte
Maykop State Technological University
Russian Federation
Russian Federation
E. A. Lyalyukova
Omsk State Medical University
Russian Federation
Russian Federation
S. K. Zhachemuk
Maykop State Technological University
Russian Federation
Russian Federation
Z. A. Beslangurova
Maykop State Technological University
Russian Federation
Russian Federation
G. N. Zhernakova
Omsk State Medical University
Russian Federation
Russian Federation
References
1. Lazebnik L. B., Golovanova E. V., Turkina S. V. et al. Non-alcoholic fatty liver disease in adults: clinic, diagnosis, treatment. Recommendations for therapists, the third version. Experimental and clinical gastroenterology. 2021;185(1): 4-52. doi: 10.31146/1682-8658-ecg-185-1-4-52 (in Russ.)@@ Лазебник Л. Б., Голованова Е. В., Туркина С. В. и соавт. Неалкогольная жировая болезнь печени у взрослых: клиника, диагностика, лечение. Рекомендации для терапевтов, третья версия. Экспериментальная и клиническая гастроэнтерология. 2021;185(1): 4-52. doi: 10.31146/1682-8658-ecg-185-1-4-52
2. Ivashkin V. T., Mayevskaya M. V., Zharkova M. S. et al. Clinical recommendations of the Russian Society for the Study of the Liver, the Russian Gastroenterological Association, the Russian Association of Endocrinologists, the Russian Association of Gerontologists and Geriatricians and the National Society of Preventive Cardiology for the diagnosis and treatment of non-alcoholic fatty liver disease.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(4):104-140. doi: 10.22416/1382-4376-2022-32-4-104-140 (in Russ.)@@ Ивашкин В. Т., Маевская М. В., Жаркова М. С. и соавт. Клинические рекомендации Российского общества по изучению печени, Российской гастроэнтерологической ассоциации, Российской ассоциации эндокринологов, Российской ассоциации геронтологов и гериатров и Национального общества профилактической кардиологии по диагностике и лечению неалкогольной жировой болезни печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022;32(4):104-140. doi: 10.22416/1382-4376-2022-32-4-104-140.
3. Mayev I. V., Andreev D. N., Kucheryavy Yu. A. Metabolically associated fatty liver disease - a disease of the XXI century. Consilium Medicum. 2022;24(5):325-332. (in Russ.) doi: 10.26442/20751753.2022.5.201532.@@ Маев И. В., Андреев Д. Н., Кучерявый Ю. А. Метаболически ассоциированная жировая болезнь печени - заболевание XXI века. Consilium Medicum. 2022;24(5):325-332. (in Russ.) doi: 10.26442/20751753.2022.5.201532.
4. Kim G.A., Lee H. C., Choe J. et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2017 Nov 2: S0168-8278(17)32294-8. doi: 10.1016/j.jhep.2017.09.012.
5. Schwartz M.W., Seeley R. J., Zeltser L. M. et al. Obesity pathogenesis: an endocrine society scientific statement. Endocrine reviews. 2017;38: 267-296.
6. Maev I.V., Samsonov A. A., Lazebnik L. B. et al. A New, NonInvasive Scale for Steatosis Developed Using Real- World Data From Russian Outpatients to Aid in the Diagnosis of Non- Alcoholic Fatty Liver Disease. Adv Ther. 2020;37:4627-4640. (in Russ.) doi: 10.1007/s12325-020-01493-w.@@ Маев И. В., Самсонов А. А., Лазебник Л. Б. и соавт. Новая неинвазивная шкала стеатоза, разработанная с использованием реальных данных российских амбулаторных пациентов для помощи в диагностике неалкогольной жировой болезни печени. Adv. 2020;(37):4627-4640. doi: 10.1007/s12325-020-01493- w.
7. Ruzhenkov V. A., Zakharova L. I., Khamskaya I. S. et al.Russian-language adaptation of the ORTO-15 test for screening diagnostics of orthorexia nervosa. Bulletin of Neurology, Psychiatry and Neurosurgery. 2019. No.8. (in Russ.)@@ Руженков В. А., Захарова Л. И., Хамская И. С. и соавт. Русскоязычная адаптация теста «ORTO-15» для скрининг-диагностики нервной орторексии. Вестник неврологии, психиатрии и нейрохирургии, 2019. № 8.
8. John Camm A., Malik M. Heart rate variability. Recommendations of the working group of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Bulletin of Arrhythmology. 1999, No.11, pp. 53-78.
9. Gudinova J. V. Friendly statistics: statistical analysis of medical databases: step-by-step instructions. J. V. Gudinova, G. N. Zhernakova, E. I. Tolkova. Omsk. Omsk State Medical University, 2014. 112 p. (in Russ.)@@ Гудинова, Ж. В. Дружелюбная статистика: статистический анализ медицинских баз данных: пошаговые инструкции / Ж. В. Гудинова, Г. Н. Жернакова, Е. И. Толькова. - Омск: Омский государственный медицинский университет, 2014. - 112 с.
10. Grzybovsky A.M., Ivanov S. V., Gorbatova M. A. Correlation analysis of data using Statistica and SPSS software. Science and Healthcare. 2017, No.1, pp. 7-36. (in Russ.)@@ Гржибовский А. М., Иванов С. В., Горбатова М. А. Корреляционный анализ данных с использованием программного обеспечения Statistica и SPSS. Наука и Здравоохранение. 2017. № 1. С. 7-36.
11. Jensen M.D., Ryan D. H., Apovian C. M. et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63: 2985-3023.
12. Mechanick J., Apovian C., Brethauer S. et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020 Feb; 16(2):175-247. doi: 10.1016/j.soard.2019.10.025.
13. Brown J., Clarke C., Johnson S. C., Sievenpiper J. Canadian Adult Obesity Clinical Practice Guidelines: Medical Nutrition Therapy in Obesity Management. 2020. Available at: https://obesitycanada.ca/guidelines/nutrition/.
14. Garvey W.T., Mechanick J. I., Brett E. M. et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016 Jul;22 Suppl 3:1-203. doi: 10.4158/EP161365.GL.
15. Boulé NG, D. Ph. Canadian Adult Obesity Clinical Practice Guidelines: Physical Activity in Obesity Management. 2021 [cited 2021 May 3, 2021]. Available at: https://obesitycanada.ca/guidelines/physicalactivity.
16. Freedhoff Y., Hall K. D. Weight loss diet studies: we need help not hype. Lancet (London, England) 2016;388: 849-851.
17. Roitberg G. E., Sharkhun O. O. Assessment of risk factors for non-alcoholic fatty liver disease. #01/17 | “The attending physician” is a professional medical publication for doctors. Scientific articles. Available at: https://www.lvrach.ru/2017/01/15436644 (in Russ.)@@ Г. Е. Ройтберг, О. О. Шархун. Оценка факторов риска неалкогольной жировой болезни печени. #01/17 | «Лечащий врач» - профессиональное медицинское издание для врачей. Научные статьи. URL: https://www.lvrach.ru/2017/01/15436644.
18. Cardi V., Tchanturia K., Treasure J. Premorbid and Illness-related Social Difficulties in Eating Disorders: An Overview of the Literature and Treatment Developments. Curr Neuropharmacol. 2018;16(8):1122-1130. doi: 10.2174/1570159X16666180118100028.
19. Naratova N. A. [In the shadow of the body]. Ulyanovsk. UGU publishing house, 2008, 208 p. (in Russ.)@@ Наратова Н. А. В тени тела / Н. А. Наратов, Е. Л. Омельченко. - Ульяновск: издательство, УГУ, 2008. - 208 с.
20. Koch C., Augustine R., Steger J. et al. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. Journal of Neuroscience. 2010;30(48):16180-16187.
21. Mikhailov V. M. [Heart rate variability: the experience of practical application of the method]. Ivanovo, Ivanovo medical academy. Publ., 2002, 288 p. (in Russ.) ISBN: 5-89085-096-2.@@ Михайлов В. М., Вариабельность ритма сердца: опыт практического применения метода / В. М. Михайлов; М-во здравоохранения РФ. Иван. гос. мед. акад. - 2. изд., перераб. и доп. - Иваново: Иван. гос. мед. акад., 2002 (Иван. обл. тип.). - 288 с., [6] л. цв. ил.: ил., табл.; 30 см.; ISBN 5-89085-096-2.
Review
For citations:
Khalashte A.A., Lyalyukova E.A., Zhachemuk S.K., Beslangurova Z.A., Zhernakova G.N. Eating behavior in patients with metabolically associated fatty liver disease. Experimental and Clinical Gastroenterology. 2024;(5):90-99. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-225-5-90-99
Views:
2575
Email this article 